Harrow HROW Return on equity

Return on equity at other companies

AbbVieABBV

89%+32.7pp

Eton Pharmaceuticals, Inc.ETON

-34.2%+0.9pp

Bausch + LombBLCO

-2.7%-0.7pp

Ocular TherapeutixOCUL

-68.6%+17.0pp

Opko HealthOPK

-5.9%-2.1pp

Tarsus Pharmaceuticals, Inc.TARS

-13.7%-4.9pp

FAQ

What is Harrow's return on equity?

Harrow (HROW) reported return on equity of -50% in Q3 2024.

How has Harrow's return on equity changed year-over-year?

Harrow's return on equity decreased by 26.0% year-over-year, from -39.7% to -50%.

What is the long-term trend for Harrow's return on equity?

Over 2 years (2021 to 2023), Harrow's return on equity has grown at a -27.2% compound annual growth rate (CAGR), from -93.6% to -49.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.